<DOC>
	<DOCNO>NCT00479648</DOCNO>
	<brief_summary>Current influenza vaccine reduce efficacy elderly . This study investigate immunogenicity , safety tolerability adjuvanted influenza vaccine elderly participant .</brief_summary>
	<brief_title>A Phase 2 Study Immunogenicity , Safety Tolerability CSL412 Elderly Participants</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged ≥ 18 ≤ 45 OR ≥ 60 Ability provide prevaccination venous blood sample History clinically significant medical condition Immunomodulative therapy Acute infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>